Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Agios Pharmaceuticals (AGIO) Cost of Revenue: 2018-2025

Historic Cost of Revenue for Agios Pharmaceuticals (AGIO) over the last 6 years, with Sep 2025 value amounting to $1.7 million.

  • Agios Pharmaceuticals' Cost of Revenue rose 114.43% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.7 million, marking a year-over-year increase of 64.02%. This contributed to the annual value of $4.2 million for FY2024, which is 44.57% up from last year.
  • Agios Pharmaceuticals' Cost of Revenue amounted to $1.7 million in Q3 2025, which was down 1.35% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, Agios Pharmaceuticals' Cost of Revenue peaked at $1.7 million during Q2 2025, and registered a low of $339,000 during Q1 2022.
  • In the last 3 years, Agios Pharmaceuticals' Cost of Revenue had a median value of $1.1 million in 2025 and averaged $1.0 million.
  • Data for Agios Pharmaceuticals' Cost of Revenue shows a peak YoY soared of 154.71% (in 2023) over the last 5 years.
  • Over the past 4 years, Agios Pharmaceuticals' Cost of Revenue (Quarterly) stood at $413,000 in 2022, then skyrocketed by 41.89% to $586,000 in 2023, then soared by 115.02% to $1.3 million in 2024, then skyrocketed by 114.43% to $1.7 million in 2025.
  • Its Cost of Revenue stands at $1.7 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.1 million for Q1 2025.